News

May 12, 2016May 12, 2016

anti-TNFα Antibodies Could Decrease Microparticles Present in Severe Psoriasis

News

Psoriasis is associated with atherosclerosis, in which circulating microparticles play a key role. A new research study demonstrated that the increased levels of circulating CD41a and CD31 microparticles were unchanged after anti-IL-12/23 ... Read more

May 12, 2016May 19, 2016

Phase 2 Trial of Prurisol for Psoriasis to be Unblinded, Promising Result Expected

News

Cellceutix Corporation recently announced that the clinical database for the phase 2 clinical trial of Prurisol, for treatment of mild-to-moderate chronic plaque psoriasis, will be ‘unblinded’ within the next few ... Read more

May 11, 2016May 11, 2016

Study Finds 2 Types of Psoriasis, Palmoplantar Pustulosis and Palmoplantar Pustular, Are Related Ills

News

Data from a gene expression array shows that palmoplantar postulosis (PPP) and palmoplantar pustular psoriasis (PPPP) are genetically similar diseases but different from psoriasis vulgaris, the most common form of psoriasis. ... Read more

May 6, 2016May 6, 2016

Sun Pharma Reports Positive Phase 3 Results for Plaque Psoriasis Treatment

News

Sun Pharma recently reported that two pivotal Phase 3 studies, assessing the safety and efficacy of the IL-23p19 inhibitor antibody tildrakizumab (MK-3222) in patients with moderate-to-severe plaque psoriasis, met their primary endpoints ... Read more

May 5, 2016May 5, 2016

Eli Lilly Announces Its Psoriasis Treatment, Taltz, Is Now Available in the US

News

Eli Lilly and Company has announced that Taltz injection 80 mg/mL is now available by prescription order in the U.S. for the treatment of moderate-to-severe plaque psoriasis. Taltz (ixekizumab) was approved ... Read more

May 4, 2016May 4, 2016

Possible Genetic Mechanism Links Psoriasis with Obesity, Danish Twin Study Indicates

News

A possible common genetic mechanism linking psoriasis and metabolic syndromes, including obesity, is the key finding of a recent report performed with Danish twins by a team of researchers at the University of Copenhagen in Denmark. ... Read more

May 3, 2016

Largest American Psoriasis Registry to Track Newly Approved Plaque Psoriasis Treatment Ixekizumab

News

The Corrona Psoriasis Registry, a 16-year independent registry with no ownership links to the pharmaceutical industry and the leading sponsor of registries in autoimmune diseases, and the National Psoriasis Foundation ... Read more

April 29, 2016

Study Links Psoriasis Severity to Increased Risk of Abdominal Aortic Aneurysm

News

People with psoriasis are at increased risk of developing abdominal aortic aneurysms (AAA), according to a new study published in the journal Arteriosclerosis, Thrombosis and Vascular Biology. In the study, ... Read more

April 28, 2016April 28, 2016

Phase 1 Trial for Chronic Plaque Psoriasis Treatment Launched by Exicure

News

Exicure, a company developing a new class of immunomodulatory and gene-silencing drugs including Spherical Nucleic Acid (SNA), has just announced the dosing of the first patient in its Phase 1 ... Read more

April 27, 2016April 27, 2016

New Psoriasis Treatment Strategies Spurred by Genetic Research

News

A team of researchers from the Vlaams Institute for Biotechnology (VIB) in Belgium discovered a molecular mechanism by which specific mutations in the protein coding gene CARD14 can lead to abnormal inflammation ... Read more